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Cytosine methylation is found in the genomes of many plants and animals and has been associated with
transcriptional silencing in mammals. At critical stages in embryo development, when cellular potential is
reset, DNAmethylation is lost in a series of ‘‘sequential waves.’’ The mechanism underlying this is controver-
sial and complex. Several new reports now suggest that TET enzymes and cell division are important for
these in vivo transitions as well as for experimentally induced reprogramming.Introduction
In mammalian cells, DNA methylation occurs exclusively at the
C5 position of cytosine, predominantly in the context of CpG
dinucleotides. It is generated and maintained by two general
classes of enzymes: the de novo methyltransferases, such
as DNMT3a and 3b, which set up DNA methylation patterns
in early development, and the maintenance methyltrans-
ferases, such as DNMT1, which copy those patterns onto
daughter strands during DNA replication as cells divide.
Because 5-methylcytosine (5-mC) is a rather stable epigenetic
modification, cytosine methylation was initially viewed as
being essentially unidirectional and this has prompted some
heated discussions about how DNA methylation could be
erased in vivo and whether DNA replication is required for
erasure or not (Wu and Zhang, 2010). In principle, active (repli-
cation-independent) DNA demethylation could be achieved
by removal of the the methyl group, by removal of the base
itself, or by conversion of the base into an intermediate
that could be resolved or replaced by unmodified cytosine.
In contrast to this scenario, cytosine methylation would be
progressively lost in dividing cells by passive dilution if,
for example, the maintenance methyltransferase DNMT1 or
its cofactor UHRF1 are absent or somehow diverted. The
discovery that TET enzymes can catalyze the conversion of
5-mC to 5-hmC in vivo (Figure 1, upper panel) (reviewed in
Pastor et al., 2013) and that 5-hmC is no longer recognized
by UHRF1 (Hashimoto et al., 2012) suggests that replication-
dependent and -independent processes could combine to
bolster the regulated loss of methylcytosine from the genome.
In this Minireview we have highlighted three recent reports
(Blaschke et al., 2013; Ficz et al., 2013; Habibi et al., 2013)
that, together with some additional studies (Leitch et al.,
2013; Yin et al., 2013), have shown that ESCs grown in
the presence of Erk1/2 and Gsk3b inhibitors (so-called 2i
conditions) achieve a ‘‘naive state’’ in which the genome
becomes hypomethylated (and reminiscent of early blasto-
meres seen in vivo) by potentiating Tet-mediated conversion
of 5-mC to 5-hmC while simultaneously curtailing methyltrans-
ferase activities.Chasing the Swell: Sequential Waves of Global DNA
Demethylation in the Developing Embryo
Two waves of DNA demethylation have been described that
globally reset identity in the developing mammalian embryo
(Figure 1, lower panel). The first wave occurs soon after fertili-
zation and gives rise to the totipotent zygote and subsequently
to the formation of pluripotent cells within the inner cell mass
(ICM). A second wave of reprogramming takes place later, as
Primordial Germ Cells (PGCs) develop and migrate toward the
genital ridges. These germ cells and their progeny will develop
into the haploid gametes that are required to establish the next
generation. The specialized gametes display several distinctive
epigenetic and structural traits, such as the replacement of
histones by the arginine-rich nuclear protamines, which must
be replaced or erased shortly after fertilization to allow the
zygote to undergo transcriptional activation and regain pluripo-
tency. The extensive remodeling that is required to reset
each parental genome is not symmetrical; the paternal pronu-
cleus undergoes active DNA demethylation, while methylation
is lost more gradually from the maternal pronucleus through
cell division and cleavage (Santos et al., 2002). Loss of CpG
methylation from the paternal genome is achieved by TET3-
mediated oxidation (Gu et al., 2011; Iqbal et al., 2011; Wossidlo
et al., 2011), while the maternal pronucleus remains protected
from TET3 activity by PGC7 (Nakamura et al., 2012), and both
are reliant upon passive DNA demethylation achieved through
inefficient maintenance (Rougier et al., 1998, Gu et al., 2011).
Oxidation of 5-hmC to 5-formylcytosine (5-fC) and 5-carboxy-
methylcytosine (5-caC) may also contribute to replication-
independent DNA demethylation, and a significant role for DNA
repair in reinstating an unmodified CpG state has also been
proposed (Inoue et al., 2011; Hajkova et al., 2010; Wossidlo
et al., 2010).
Once the pluripotent ICM is established, there is extensive de
novo methylation as the embryonic lineages are specified. A
subset of cells within the epiblast, from which the PGCs arise,
undergo a second wave of reprogramming in which this newly
established methylation is erased and germ cell specific genes
are reactivated. Recent studies concentrating on the timing ofCell Stem Cell 13, September 5, 2013 ª2013 Elsevier Inc. 265
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Figure 1. The Role of Tet Proteins in DNA
Demethylation
The upper panel depicts the Tet-mediated oxida-
tion of 5mC (upper) to generate 5hmC (middle),
which is subsequently converted, by different
agents and processes, to unmodified cytosine
(lower). The methyl group is shown in red and the
hydroxyl group is shown in yellow. The lower panel
depicts the DNA methylation status of tissues at
progressive stages of early mouse development
from E0 to E13.5. Transitions where Tet proteins
are critical are highlighted (surf board) and waves
of DNA methylation and demethylation are indi-
cated. Global methylation profiles of ESCs derived
from the ICM, and grown in serum plus LIF, 2i, or
2i plus vitamin C are shown, in which increased
hypomethylation is evident.
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order of events; demethylation begins as PGCs are specified
and targets the promoters of a wide range of genes including
markers of pluripotency and germ cells, and loss of methylation
at Imprinted Control Regions (ICRs) occurs later, with LINE re-
peats and X-linked loci resisting demethylation until cells enter
the gonads (Guibert et al., 2012; Seisenberger et al., 2012). In vivo
BrdU incorporation studies have revealed that PGCs divide
between E9.5 and E12.5, with a calculated division rate of
once every 12.6 hr (Kagiwada et al., 2013). This, together with
the downregulation of Dnmt3a, 3b, 3l, and Uhrf1, may provide
an opportunity for passive demethylation during the first few
days of PGC migration (Kagiwada et al., 2013; Seisenberger
et al., 2012). PGCs express maximal Tet1 and Tet2 levels
between E9.5 and E10.5 (potentially converting 5-mC to
5-hmC globally), while BER components are prominent only at
later stages, but both may contribute to the removal of 5-mC
at different regions of the genome (Hackett et al., 2013; Hajkova
et al., 2010; Kagiwada et al., 2013).
Global Hypomethylation of ESCs Is Induced by 2i
and Generates a Naive but Immortal State
Examining the biology of reprogramming in vivo has been chal-
lenging because it requires access to a very small number of266 Cell Stem Cell 13, September 5, 2013 ª2013 Elsevier Inc.embryonic cells that are in constant flux
(Hackett et al., 2013; Santos et al., 2002;
Smith et al., 2012). Embryonic stem cells
(ESCs) that are derived from the preim-
plantation blastocyst have been widely
used as immortal surrogates to represent
the pluripotent epiblast and ICM (Nichols
and Smith, 2009). ESCs grown or isolated
in serum supplemented with leukemia
inhibitory factor (LIF) are, however, sur-
prisingly heterogeneous, as exemplified
by Nanog expression (Chambers et al.,
2007), and are primed to differentiate.
Growth in media supplemented with two
small-molecule kinase inhibitors (2i) pro-
motes the establishment of a ground
state of pluripotency (Ying et al., 2008) in
which cells aremuch less heterogeneous,and several recent studies have begun to unravel the epigenetic
basis of this ground state (Leitch et al., 2013; Blaschke et al.,
2013; Ficz et al., 2013; Habibi et al., 2013). Earlier this year,
Leitch, Hajkova, and collaborators (Leitch et al., 2013) demon-
strated that several ESC lines isolated under 2i conditions
(ES-2i) were hypomethyated as compared to those derived in
conventional serum-based media (ES-serum) (Figure 1, lower
panel, left). Loss of methylation was apparent at CpG islands
and included LINE1 elements and minor and major satellite
sequences, while IAPs and differentially methylated regions
(DMRs) of imprinted genes resisted demethylation. A shift in
methylation profiles was evident as early as five passages after
2i addition, and the authors tracked this down to a rapid decline
of Dnmt3a, 3b, and 3l genes in 2i conditions that was in part
mediated by PRDM14 repressing Dnmt3b (Leitch et al., 2013).
New data from the Reik and Stunnenberg laboratories not only
confirm and expand these analyses, but they also suggest that
2i enhances TET1/2 activity (and consequently 5-hmC levels),
thereby providing an explanation for impaired maintenance
methylation and ‘‘passive’’ loss of DNA methylation seen in
ESCs switched to 2i conditions (Ficz et al., 2013; Habibi et al.,
2013). Both new studies showed that methylcytosine was lost
from gene bodies, non-CGI and CGI promoters, SINE and
LINE1 elements, and enhancers and bivalent loci upon 2i
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ICRs remained protected. Habibi et al. showed that regions
that maintained DNA methylation correlated with those marked
by H3K9me3 both in serum and in 2i, while TET1 target loci
were particularly sensitive to DNA demethylation (Habibi
et al., 2013). To understand how these findings relate to the
waves of reprogramming that occur in vivo, these global
methylation data sets were compared to those obtained from
different stages of ICM and PGC development. This compari-
son revealed a close correspondence between ESCs grown
in 2i and ex vivo cells from the mouse ICM at E3.5, or migratory
PGCs at E9.5. In contrast, the high levels of 5-mC detected
in ESCs grown in serum plus LIF resembled the methylome
of cells isolated from the postimplantation mouse epiblast at
around E6.5 (Ficz et al., 2013; Habibi et al., 2013) (Figure 1,
lower panel).
Tet-Mediated Conversion of 5-mC to 5-hmC
Is Enhanced by Vitamin C
Vitamin C, or ascorbate, has recently emerged as a factor facil-
itating DNA demethylation. It is a necessary supplement in
human embryonic stem cell (hESC) media because cells stop
proliferating two or three passages after its removal and require
higher concentrations of b-FGF to be maintained (Chung et al.,
2010). Vitamin C regulates the demethylation of promoter
regions of more than 1,800 genes in hESCs, where it is asso-
ciated with increased expression of a subset of these genes,
which are implicated in cellular growth, proliferation, and
pluripotency. In iPSC reprogramming, vitamin C is thought to
overcome the senescence block and facilitate the pre-iPSC
transition (Esteban et al., 2010), enhance the activity of
H3K36 demethylases (Wang et al., 2011), and prevent
imprinted Dlk1-Dio3 erasure (Stadtfeld et al., 2012), all of which
are important for increasing reprogramming efficacy. New
studies from the laboratories of Ramalho-Santos, Wang, and
Wang reveal a central role for TET proteins in this process
(Blaschke et al., 2013, Minor et al., 2013; Yin et al., 2013).
Treatment of mouse embryonic fibroblasts with vitamin C has
been reported to result in a rapid increase (within 1 hr) in the
abundance of 5-hmC, without any apparent change in Tet
levels (Minor et al., 2013). Vitamin C can interact with the cata-
lytic domains of TET1 and TET2 and enhance their enzymatic
activity by altering structure and helping with product recycling.
Mouse ESCs contain high levels of TET1 and TET2 and vitamin
C addition is reported to result in a substantial and rapid in-
crease in the level of genome-wide 5-hmC (Blaschke et al.,
2013; Yin et al., 2013). Yin and colleagues have shown that
global 5-mC levels in ESCs fell by 40% within 3 days of treat-
ment and that this decline was dependent on TET1/TET2
(Yin et al., 2013). Blaschke et al. demonstrated that mouse
ESCs grown in 2i progressively lose 5-mC at the promoters
of previously methylated genes 12–72 hr after vitamin C addi-
tion (Blaschke et al., 2013). Because repetitive elements such
as IAPs and ICRs gain 5-hmC upon vitamin C treatment, but
remain protected from subsequent demethylation, the authors
have suggested that this epigenetic profile resembles that of
the in vivo early blastocyst and claim that (irrespective of 2i)
without vitamin C, mouse ESCs acquire an epiblast-like methyl-
ation profile.Harnessing the Waves: A Role for Tet Proteins and Cell
Division in Experimental Reprogramming
Cells progressively acquire stable lineage-specific patterns of
DNA methylation as they differentiate. This inherited epigenetic
memory is difficult to fully erase by standard experimental re-
programming approaches (Bock et al., 2011). A better under-
standing of how DNA demethylation is achieved in vivo and
how lineage identity is properly reset might be hugely informative
for streamlining the transdifferentiation and dedifferentiation
reprogramming strategies currently being developed for thera-
peutic purposes. In this regard, several recent studies have
focused on the likely contribution of TET proteins to specific
reprogramming scenarios (Doege et al., 2012; Costa et al.,
2013; Gao et al., 2013; Piccolo et al., 2013; Vincent et al.,
2013). Doege et al. have shown that the overexpression of
Oct4, Sox2, Klf4, and c-Myc (OSKM) in mouse embryonic fibro-
blasts (MEFs) activated Tet2 expression (Tet1 and Tet3 levels
remained unchanged) and induced an increase in 5-hmC levels
globally, as determined by immunofluorescence. Increased
hydroxylation was evident at various pluripotent loci such as
Nanog and Esrrb (Doege et al., 2012), implicating TET2-medi-
ated hydroxylation in pluripotent reprogramming. Consistent
with this idea, TET2-depleted MEFs were unable to generate
OSKM-induced iPSC colonies. From this, the authors have
argued that 5-hmC, rather than being an intermediate in 5-mC
demethylation, could act as an independent epigenetic modifi-
cation (Doege et al., 2012). In a related study in which the
physical interaction between TET proteins and NANOG was
described (Costa et al., 2013), overexpression of both of these
factors was shown to enhance reprogramming while depletion
of Tet1 reduced iPSC formation by MEFs. TET1 and NANOG
were envisaged to act together and enhance the hydroxylation
of loci such as Esrrb andOct4, priming these genes for both acti-
vation and demethylation. Because TET2 can also physically
associate with NANOG, TET2 overexpression, like TET1 overex-
pression, increased the efficiency of iPSC formation. The extent
of the overlap between TET1 and TET2 target genes and the
extent to which these endogenous proteins can compensate
each other, however, remain largely unknown.
A recent reprogramming study has confirmed that TET1-
mediated hydroxylation of the Oct4 gene is accompanied by
eventual demethylation, changes in histone modifications, and
changes in gene reactivation, and it has shown that TET1 can
substitute for OCT4 in an OSKM reprogramming cocktail (Gao
et al., 2013). This substitution generated cells with lower 5-mC
and higher 5-hmC than conventional iPSCs, which the authors
have speculated might be significant in reducing the tumorigenic
potential of this important cell type. Our laboratory has also
shown, using a cell fusion-based system, that TET1 and TET2
are important for different aspects of pluripotent reprogramming
(Piccolo et al., 2013). The study showed that Embryonic Germ
Cells (EGCs) derived from late PGCs were able to induce imprint
erasure from the genome of a somatic cell fusion partner and that
this was critically dependent on TET1. Although the somatic
genome accumulated 5-hmC at several ICRs within 2–3 days
of fusion to EGCs, complete reversion to unmodified CpGs
was protracted and required multiple rounds of cell division,
similar to the dynamics of PGC development seen in vivo
(Piccolo et al., 2013). Pluripotent reprogramming induced byCell Stem Cell 13, September 5, 2013 ª2013 Elsevier Inc. 267
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accumulation of 5-hmC at pluripotency loci within the somatic
genome (such as Oct4), a process that may require Tet2, but is
critically dependent uponDNA synthesis within the newly formed
heterokaryons (Tsubouchi et al., 2013; Foshay et al., 2012;
Piccolo et al., 2013). In another recent study in which ESCs
were used to generate induced PGCs (iPGCs) expressing Blimp1
and Dpp3, genome-wide demethylation was shown to occur in
two successive stages, somewhat reminiscent of PGC develop-
ment in vivo. iPGCs generated from Tet2 null ESCs depleted of
Tet1 showed a global reduction in 5-mC across the genome,
but remained hypermethylated at specific loci (Vincent et al.,
2013). The authors have interpreted this to mean that Tet1,
Tet2, and 5-hmC may be dispensable for initial steps in DNA
demethylation but are required to enable the re-expression of
specific germ-cell-associated genes. This observation under-
scores the importance of impaired methylation maintenance,
coupled to cell division, as a likely mechanism for generating
genome-scale loss of 5-mC in vitro.
Conclusions
ESCs that lack both de novo and maintenance methyltransfer-
ase activities show a predictable lack of 5-mC but remain plurip-
otent, as judged by alkaline phosphatase activity and expression
of a variety of pluipotency-associated genes (Tsumura et al.,
2006). Likewise, ESCs lacking DNMT1, DNMT3a, and DNMT3b
can give rise to pluripotent cells upon nuclear transfer, but the
resultant cells contribute mostly to the extraembryonic tissues
(Sakaue et al., 2010). These data suggest that although embry-
onic cell lines are relatively tolerant to an absence of DNA
methylation, execution of their pluripotent status is difficult in
the absence of stable gene silencing. Consistent with this idea,
a recent study has shown that although ESCs lacking DNMT1,
DNMT3a, and DNMT3b can differentiate to generate embryoid
bodies in vitro, they fail to silence Oct4 completely and were
prone to revert to an undifferentiated state (Schmidt et al.,
2012). These studies, when taken together, emphasize that
DNA methylation is not required to establish or maintain pluri-
potency, but it is vital in securing the stable transition toward
differentiated progeny.
In this Minireview we have tried to capture some of the most
recent developments within a fast- moving field in which the
roles of TET proteins and cell division in DNA demethylation
during experimental and ‘‘natural’’ reprogramming are being
scrutinized. Evidence from a range of different in vitro reprog-
ramming studies has suggested that TET proteins and/or
replication-dependent (passive demethylation) processes prob-
ably underlie the conversion to an ESC-like or PGC-like state.
Deletion of Tet1 or Tet2 in mice was initially shown to have little
effect on their fertility or methylome, but these reports have given
way to new studies showing a predictable increase in 5-mC
levels in the absence of both Tet1 and Tet2 (Dawlaty et al.,
2013). Whether some of the differences between in-vitro- and
in-vivo-based studies reflect compensation by maternally
derived Tet proteins, by Tet3, or by other demethylating factors
remains unclear. However, these possibilities highlight the need
to investigate redundancy between Tet family members and
discover the mechanisms that recruit specific Tet proteins to
particular subsets of genes. A more fundamental uncertainty in268 Cell Stem Cell 13, September 5, 2013 ª2013 Elsevier Inc.the field focuses on whether 5-hmC represents an intermediate
in cytosine demethylation, or alternatively, represents an inde-
pendent epigenetic mark that delineates loci that are potentially
active or that are about to be expressed.
We have highlighted three new papers that show that ESCs
grown in circumstances where FGF and Erk signaling is in-
hibited, and supplemented with vitamin C, become hypomethy-
lated and display a methylome that resembles that of cells
within the ICM or of PGCs. All of these studies, as well as
some prior reports, have implicated TET proteins and 5-hmC in
these transitions. As well as providing a plausible explanation
for the perplexingly high global levels of cytosine methylation
detected in conventionally grown ESCs, these studies have
begun to exploit new genome-scale technologies that will aid
our understanding of how signaling can fundamentally reset
and reprogram the genome. While considerable debate remains
regarding the relative importance of specific factors and pro-
cesses in achieving this transition, it is likely that an intimate
understanding of how global waves of demethylation shape
the developing embryo will be important for improving efficacy
and safety in experimental reprogramming. As an increasing
number of laboratories strive to better understand and interro-
gate these waves of DNA demethylation, it is sobering to
remember that surfing (or he’e nalu) is an ancient pastime, often
described as one of the purest sports where the rider engages
directly with an ever-changing environment. With this in mind,
and with so much still to discover, there may never have been
a better time to fashion your board and take to the water.ACKNOWLEDGMENTS
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